Bonnotte B - Search Results

1

Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones.

Garrido C, Fromentin A, Bonnotte B, Favre N, Moutet M, Arrigo AP, Mehlen P, Solary E. Garrido C, et al. Among authors: bonnotte b. Cancer Res. 1998 Dec 1;58(23):5495-9. Cancer Res. 1998. PMID: 9850085

2

High concentrations of intrathecal interleukin-6 in human bacterial and nonbacterial meningitis.

Chavanet P, Bonnotte B, Guiguet M, Zeller V, Solary E, Maurice L, Casasnovas O, Caillot D, Waldner A, Kisterman JP, et al. Chavanet P, et al. Among authors: bonnotte b. J Infect Dis. 1992 Aug;166(2):428-31. doi: 10.1093/infdis/166.2.428. J Infect Dis. 1992. PMID: 1634815

3

A controlled trial of the tolerance of amphotericin B infused in dextrose or in Intralipid in patients with haematological malignancies.

Caillot D, Reny G, Solary E, Casasnovas O, Chavanet P, Bonnotte B, Perello L, Dumas M, Entezam F, Guy H. Caillot D, et al. Among authors: bonnotte b. J Antimicrob Chemother. 1994 Mar;33(3):603-13. doi: 10.1093/jac/33.3.603. J Antimicrob Chemother. 1994. PMID: 8040124 Clinical Trial.

4

Efficacy and tolerance of an amphotericin B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients.

Caillot D, Casasnovas O, Solary E, Chavanet P, Bonnotte B, Reny G, Entezam F, Lopez J, Bonnin A, Guy H. Caillot D, et al. Among authors: bonnotte b. J Antimicrob Chemother. 1993 Jan;31(1):161-9. doi: 10.1093/jac/31.1.161. J Antimicrob Chemother. 1993. PMID: 8444659

5

Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression. A role in the immune tolerance to antigenic tumors.

Chaux P, Favre N, Bonnotte B, Moutet M, Martin M, Martin F. Chaux P, et al. Among authors: bonnotte b. Adv Exp Med Biol. 1997;417:525-8. doi: 10.1007/978-1-4757-9966-8_86. Adv Exp Med Biol. 1997. PMID: 9286414 No abstract available.

6

Bcl-2-mediated inhibition of apoptosis prevents immunogenicity and restores tumorigenicity of spontaneously regressive tumors.

Bonnotte B, Favre N, Moutet M, Fromentin A, Solary E, Martin M, Martin F. Bonnotte B, et al. J Immunol. 1998 Aug 1;161(3):1433-8. J Immunol. 1998. PMID: 9686608

7

Cancer cell sensitization to fas-mediated apoptosis by sodium butyrate.

Bonnotte B, Favre N, Reveneau S, Micheau O, Droin N, Garrido C, Fontana A, Chauffert B, Solary E, Martin F. Bonnotte B, et al. Cell Death Differ. 1998 Jun;5(6):480-7. doi: 10.1038/sj.cdd.4400371. Cell Death Differ. 1998. PMID: 10200499

8

FAS(CD95) ligand expression by tumor cell variants can be unrelated to their capacity to induce tolerance or immune rejection.

Favre N, Bonnotte B, Droin N, Fromentin A, Solary E, Martin F. Favre N, et al. Among authors: bonnotte b. Int J Cancer. 1999 Jul 30;82(3):359-67. doi: 10.1002/(sici)1097-0215(19990730)82:3<359::aid-ijc9>3.0.co;2-k. Int J Cancer. 1999. PMID: 10399953

9

Role of tumor cell apoptosis in tumor antigen migration to the draining lymph nodes.

Bonnotte B, Favre N, Moutet M, Fromentin A, Solary E, Martin M, Martin F. Bonnotte B, et al. J Immunol. 2000 Feb 15;164(4):1995-2000. doi: 10.4049/jimmunol.164.4.1995. J Immunol. 2000. PMID: 10657650

10

Cutting edge: the tumor counterattack hypothesis revisited: colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway.

Favre-Felix N, Fromentin A, Hammann A, Solary E, Martin F, Bonnotte B. Favre-Felix N, et al. Among authors: bonnotte b. J Immunol. 2000 May 15;164(10):5023-7. doi: 10.4049/jimmunol.164.10.5023. J Immunol. 2000. PMID: 10799856

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters